Here are five things to note:
1. In his new role, Mr. Lyons will drive sales of the company’s silicon nitride implants in the spinal fusion market.
2. With more than 27 years of sales and sales management experience in the medical device field, Mr. Lyons previously held leadership positions at Stryker’s orthopedics division and Zimmer Biomet’s spine division.
3. Amedica also received FDA clearance for its Taurus pedicle screw system.
4. The company plans to conduct a full market launch of the Taurus system this year.
5. Amedica didn’t receive FDA clearance for its Valeo C+CsC, which is a composite spinal fusion device. This device is already marketed in Europe with positive outcomes.
More articles on devices:
Spineway’s capital boosts nearly $1.49M — 5 notes
Reconstructive knee replacement market to reach $5B by 2020 — 5 takeaways
System detects early stages of idiopathic scoliosis with 3D scans: 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
